These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31713331)

  • 21. Clinical association: Lyme disease and Guillain-Barre syndrome.
    Patel K; Shah S; Subedi D
    Am J Emerg Med; 2017 Oct; 35(10):1583.e1-1583.e2. PubMed ID: 28711274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Jun; 12(523):1204-5. PubMed ID: 27487629
    [No Abstract]   [Full Text] [Related]  

  • 23. Steroids in the Guillain-Barré syndrome: is there a therapeutic window?
    Van Koningsveld R; Van Doorn PA
    Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470
    [No Abstract]   [Full Text] [Related]  

  • 24. Guillain-Barré syndrome presenting with loss of taste.
    Odaka M; Yuki N; Nishimoto Y; Hirata K
    Neurology; 2002 May; 58(9):1437-8. PubMed ID: 12011304
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guillain-Barré syndrome].
    Koga M; Yuki N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guillain-Barré syndrome].
    Kusunoki S
    Nihon Rinsho; 2005 May; 63 Suppl 5():427-31. PubMed ID: 15954387
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case report; A case of anti-GD1b antibody positive pure motor form Guillain-Barré syndrome with good response to combined IVIg and steroid therapy].
    Fujimoto T; Fukuda Y; Eguchi K; Kusunoki S
    Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1651-3. PubMed ID: 21770292
    [No Abstract]   [Full Text] [Related]  

  • 29. [Guillain-Barré syndrome associated with acute hepatitis A-A case report and literature review].
    Saito A; Saito M; Shimoe Y; Yoshimoto T; Kawakami M; Okamoto H; Yoshikawa K; Kusunoki S; Kuriyama M
    Rinsho Shinkeigaku; 2018 Sep; 58(9):574-577. PubMed ID: 30175808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 31. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies.
    Tobon A
    J Infus Nurs; 2017; 40(6):375-379. PubMed ID: 29112586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.
    Garssen MP; van Koningsveld R; van Doorn PA; Merkies IS; Scheltens-de Boer M; van Leusden JA; van Schaik IN; Linssen WH; Visscher F; Boon AM; Faber CG; Meulstee J; Prick MJ; van den Berg LH; Franssen H; Hiel JA; van den Bergh PY; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):1012-3. PubMed ID: 17702789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Simultaneous bilateral peripheral facial paralysis is a rare variant of Guillain-Barré syndrome].
    Frahm-Falkenberg S; de la Cour CD; Andersen PB
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bartonella henselae infection associated with Guillain-Barre syndrome.
    Massei F; Gori L; Taddeucci G; Macchia P; Maggiore G
    Pediatr Infect Dis J; 2006 Jan; 25(1):90-1. PubMed ID: 16395116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bickerstaff 's encephalitis, Guillain-Barré syndrome and idiopathic intracranial hypertension: are they related conditions?
    Damasceno A; França MC; Pimenta DS; Deus-Silva Ld; Nucci A; Damasceno BP
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):744-6. PubMed ID: 18949275
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastrointestinal prokinetic agents for enhancing drug response in gastroparesis.
    Singh PJ; Santella RN; Zawada ET
    Am J Health Syst Pharm; 1997 Nov; 54(22):2609-12. PubMed ID: 9397225
    [No Abstract]   [Full Text] [Related]  

  • 39. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
    Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
    [No Abstract]   [Full Text] [Related]  

  • 40. Miller Fisher variant of Guillain-Barré syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome.
    Chaudhary A; Ramchand T; Frohman LP; Liu JK; Eloy JA
    Laryngoscope; 2012 May; 122(5):970-2. PubMed ID: 22447677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.